220 related articles for article (PubMed ID: 26726844)
1. Disease-causing mutations of RhoGDIα induce Rac1 hyperactivation in podocytes.
Auguste D; Maier M; Baldwin C; Aoudjit L; Robins R; Gupta IR; Takano T
Small GTPases; 2016 Apr; 7(2):107-21. PubMed ID: 26726844
[TBL] [Abstract][Full Text] [Related]
2. Loss of Rho-GDIα sensitizes podocytes to lipopolysaccharide-mediated injury.
Robins R; Baldwin C; Aoudjit L; Gupta IR; Takano T
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1207-16. PubMed ID: 25503727
[TBL] [Abstract][Full Text] [Related]
3. ARHGDIA: a novel gene implicated in nephrotic syndrome.
Gupta IR; Baldwin C; Auguste D; Ha KC; El Andalousi J; Fahiminiya S; Bitzan M; Bernard C; Akbari MR; Narod SA; Rosenblatt DS; Majewski J; Takano T
J Med Genet; 2013 May; 50(5):330-8. PubMed ID: 23434736
[TBL] [Abstract][Full Text] [Related]
4. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.
Gee HY; Saisawat P; Ashraf S; Hurd TW; Vega-Warner V; Fang H; Beck BB; Gribouval O; Zhou W; Diaz KA; Natarajan S; Wiggins RC; Lovric S; Chernin G; Schoeb DS; Ovunc B; Frishberg Y; Soliman NA; Fathy HM; Goebel H; Hoefele J; Weber LT; Innis JW; Faul C; Han Z; Washburn J; Antignac C; Levy S; Otto EA; Hildebrandt F
J Clin Invest; 2013 Aug; 123(8):3243-53. PubMed ID: 23867502
[TBL] [Abstract][Full Text] [Related]
5. Kindlin-2 Association with Rho GDP-Dissociation Inhibitor
Sun Y; Guo C; Ma P; Lai Y; Yang F; Cai J; Cheng Z; Zhang K; Liu Z; Tian Y; Sheng Y; Tian R; Deng Y; Xiao G; Wu C
J Am Soc Nephrol; 2017 Dec; 28(12):3545-3562. PubMed ID: 28775002
[TBL] [Abstract][Full Text] [Related]
6. The Role of Trio, a Rho Guanine Nucleotide Exchange Factor, in Glomerular Podocytes.
Maier M; Baldwin C; Aoudjit L; Takano T
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415466
[TBL] [Abstract][Full Text] [Related]
7. Cyclic strain modulates migration and proliferation of vascular smooth muscle cells via Rho-GDIalpha, Rac1, and p38 pathway.
Qi YX; Qu MJ; Yan ZQ; Zhao D; Jiang XH; Shen BR; Jiang ZL
J Cell Biochem; 2010 Apr; 109(5):906-14. PubMed ID: 20069557
[TBL] [Abstract][Full Text] [Related]
8. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of Rho GTPase Activity in Podocytes.
Matsuda J; Takano T
Methods Mol Biol; 2023; 2664():343-349. PubMed ID: 37423999
[TBL] [Abstract][Full Text] [Related]
10. PLCE1 regulates the migration, proliferation, and differentiation of podocytes.
Yu S; Choi WI; Choi YJ; Kim HY; Hildebrandt F; Gee HY
Exp Mol Med; 2020 Apr; 52(4):594-603. PubMed ID: 32238860
[TBL] [Abstract][Full Text] [Related]
11. FAT1 mutations cause a glomerulotubular nephropathy.
Gee HY; Sadowski CE; Aggarwal PK; Porath JD; Yakulov TA; Schueler M; Lovric S; Ashraf S; Braun DA; Halbritter J; Fang H; Airik R; Vega-Warner V; Cho KJ; Chan TA; Morris LG; ffrench-Constant C; Allen N; McNeill H; Büscher R; Kyrieleis H; Wallot M; Gaspert A; Kistler T; Milford DV; Saleem MA; Keng WT; Alexander SI; Valentini RP; Licht C; Teh JC; Bogdanovic R; Koziell A; Bierzynska A; Soliman NA; Otto EA; Lifton RP; Holzman LB; Sibinga NE; Walz G; Tufro A; Hildebrandt F
Nat Commun; 2016 Feb; 7():10822. PubMed ID: 26905694
[TBL] [Abstract][Full Text] [Related]
12. Rac1 activation in podocytes induces rapid foot process effacement and proteinuria.
Yu H; Suleiman H; Kim AH; Miner JH; Dani A; Shaw AS; Akilesh S
Mol Cell Biol; 2013 Dec; 33(23):4755-64. PubMed ID: 24061480
[TBL] [Abstract][Full Text] [Related]
13. FERM domain containing protein 7 interacts with the Rho GDP dissociation inhibitor and specifically activates Rac1 signaling.
Pu J; Mao Y; Lei X; Yan Y; Lu X; Tian J; Yin X; Zhao G; Zhang B
PLoS One; 2013; 8(8):e73108. PubMed ID: 23967341
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
Scott RP; Hawley SP; Ruston J; Du J; Brakebusch C; Jones N; Pawson T
J Am Soc Nephrol; 2012 Jul; 23(7):1149-54. PubMed ID: 22518006
[TBL] [Abstract][Full Text] [Related]
15. ARHGEF7 (
Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
[TBL] [Abstract][Full Text] [Related]
16. The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury.
Tavasoli M; Li L; Al-Momany A; Zhu LF; Adam BA; Wang Z; Ballermann BJ
Kidney Int; 2016 Apr; 89(4):833-47. PubMed ID: 26924049
[TBL] [Abstract][Full Text] [Related]
17. Rho-family small GTPases are involved in forskolin-induced cell-cell contact formation of renal glomerular podocytes in vitro.
Gao SY; Li CY; Shimokawa T; Terashita T; Matsuda S; Yaoita E; Kobayashi N
Cell Tissue Res; 2007 May; 328(2):391-400. PubMed ID: 17265067
[TBL] [Abstract][Full Text] [Related]
18. The Rho-GTPase binding protein IQGAP2 is required for the glomerular filtration barrier.
Sugano Y; Lindenmeyer MT; Auberger I; Ziegler U; Segerer S; Cohen CD; Neuhauss SC; Loffing J
Kidney Int; 2015 Nov; 88(5):1047-56. PubMed ID: 26154927
[TBL] [Abstract][Full Text] [Related]
19. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
